Ameluz is a medicine used in adults to treat mild to moderate actinic keratoses, skin growths caused by exposure to sunlight, which can lead to skin cancer. It may also be used to treat an area of sun\-induced skin damage with multiple actinic keratosis growths (field cancerisation). Ameluz can also be used in adults to treat certain types of basal cell carcinoma (a type of skin cancer) when it cannot be treated by surgery. Ameluz contains the active substance 5\-aminolaevulinic acid.
Therapeutic Indication
Treatment of actinic keratosis of mild to moderate severity on the face and scalp (Olsen grade 1 to 2; see section 5\.1\) and of field cancerization in adults. Treatment of superficial and/or nodular basal cell carcinoma unsuitable for surgical treatment due to possible treatment\-related morbidity and/or poor cosmetic outcome in adults.
Therapeutic Area (MeSH)
ATC Code
L01XD04
ATC Item
N/A
Pharmacotherapeutic Group
Antineoplastic agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| 5-aminolevulinic acid hydrochloride | N/A | 5-aminolevulinic acid hydrochloride |
EMA Name
Ameluz
Medicine Name
Ameluz
Aliases
N/ANo risk management plan link.
